Lianglin Zhang

3.7k total citations · 1 hit paper
42 papers, 2.8k citations indexed

About

Lianglin Zhang is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Lianglin Zhang has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Biomaterials. Recurrent topics in Lianglin Zhang's work include Supramolecular Self-Assembly in Materials (7 papers), HER2/EGFR in Cancer Research (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Lianglin Zhang is often cited by papers focused on Supramolecular Self-Assembly in Materials (7 papers), HER2/EGFR in Cancer Research (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Lianglin Zhang collaborates with scholars based in United States, China and France. Lianglin Zhang's co-authors include Erkki Ruoslahti, Michael J. Sailor, Sangeeta N. Bhatia, Ji‐Ho Park, Geoffrey von Maltzahn, Stan Krajewski, Valentina Fogal, Michael P. Schwartz, Jason A. Hoffman and Austin M. Derfus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Lianglin Zhang

40 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Products from Herbal Medicine Self‐Assemble into Advanced Bioactive Materials

2024 86 citations Xiaohang Guo, Weikang Luo et al. Advanced Science profile →

Peers

Lianglin Zhang

BIOMA

ONCOL

Hilary Shmeeda Israel

Alberto Fernández‐Medarde Spain

Rafael T. M. de Rosales United Kingdom

David C. Blakey United Kingdom

Natascha Drude Germany

Qizhen Cao United States

Yuan Fan China

Takemi Tanaka United States

Hoe Suk Kim South Korea

Lucie Sancey France

Hilary Shmeeda Israel

Lianglin Zhang

1.7k ×1.2

2.0k ×2.2

BIOMA

1.3k ×1.7

669 ×1.2

ONCOL

305 ×0.8

Citations per year, relative to Lianglin Zhang Lianglin Zhang (= 1×) peers Hilary Shmeeda

Countries citing papers authored by Lianglin Zhang

Since Specialization

Citations

This map shows the geographic impact of Lianglin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianglin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianglin Zhang more than expected).

Fields of papers citing papers by Lianglin Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianglin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianglin Zhang. The network helps show where Lianglin Zhang may publish in the future.

Co-authorship network of co-authors of Lianglin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianglin Zhang. A scholar is included among the top collaborators of Lianglin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianglin Zhang. Lianglin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Lianglin, et al.. (2025). Urban-rural disparities and future trends in dietary water footprint across African nations. Environmental Impact Assessment Review. 114. 107967–107967.

Guo, Xiaohang, Weikang Luo, Lianglin Zhang, et al.. (2024). Natural Products from Herbal Medicine Self‐Assemble into Advanced Bioactive Materials. Advanced Science. 11(35). e2403388–e2403388. 86 indexed citations breakdown →

Li, Teng, Lianglin Zhang, Menghan Cheng, et al.. (2024). Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury. Chinese Medicine. 19(1). 131–131. 20 indexed citations

Zhang, Lianglin, et al.. (2024). How does virtual water influence the water stress pattern in Africa? A research perspective from the perspectives of production and trade. The Science of The Total Environment. 946. 174244–174244. 4 indexed citations

Zhang, Lianglin, et al.. (2023). Green synthesis of boron-doped carbon dots from Chinese herbal residues for Fe3+ sensing, anti-counterfeiting, and photodegradation applications. Journal of Cleaner Production. 422. 138577–138577. 28 indexed citations

Yin, Yandong, Carel Fijen, Lianglin Zhang, et al.. (2022). A two-step mechanism governing PARP1-DNA retention by PARP inhibitors. Science Advances. 8(36). eabq0414–eabq0414. 35 indexed citations

Ding, Xia, Zhou Zhu, John D. Lapek, et al.. (2022). PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib. Scientific Reports. 12(1). 12501–12501. 8 indexed citations

Ryan, Kevin, Ben Bolaños, Marissa L. Smith, et al.. (2020). Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1. Journal of Biological Chemistry. 296. 100251–100251. 54 indexed citations

Zhang, Lianglin, et al.. (2018). Alignment of twisted nanoribbons formed by C₁₇H₃₅CO-Val-Ala sodium salts. Soft Matter. 14(30). 6353–6359. 3 indexed citations

10.

Zhang, Lianglin. (2016). Theoretical Sources of Charles Morris’s Semiotics. 2(4). 100–115. 2 indexed citations

11.

Mateo, Joaquı́n, Jordan Berlin, Johann S. de Bono, et al.. (2014). A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 74(5). 1039–1046. 30 indexed citations

12.

Li, Gang, Lianglin Zhang, Enhong Chen, et al.. (2010). Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity. Cancer Research. 70(24). 10243–10254. 20 indexed citations

13.

Park, Ji‐Ho, Geoffrey von Maltzahn, Lianglin Zhang, et al.. (2009). Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting. Small. 5(6). 694–700. 245 indexed citations

14.

Laakkonen, Pirjo, Lianglin Zhang, & Erkki Ruoslahti. (2008). Peptide Targeting of Tumor Lymph Vessels. Annals of the New York Academy of Sciences. 1131(1). 37–43. 62 indexed citations

15.

Fogal, Valentina, Lianglin Zhang, Stan Krajewski, & Erkki Ruoslahti. (2008). Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma. Cancer Research. 68(17). 7210–7218. 282 indexed citations

16.

Zhang, Lianglin, Enrico Giraudo, Jason A. Hoffman, Douglas Hanahan, & Erkki Ruoslahti. (2006). Lymphatic Zip Codes in Premalignant Lesions and Tumors. Cancer Research. 66(11). 5696–5706. 60 indexed citations

17.

Klos, Kristine S., Xiaoyan Zhou, Sangkyou Lee, et al.. (2003). Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone. Cancer. 98(7). 1377–1385. 83 indexed citations

18.

Hoffman, Jason A., Enrico Giraudo, Mallika Singh, et al.. (2003). Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell. 4(5). 383–391. 182 indexed citations

19.

Nicolson, Garth L., Jonathan C. Trent, Dihua Yu, et al.. (2002). Characterization of 11 human sarcoma cell strains. Cancer. 95(7). 1569–1576. 9 indexed citations

20.

Wang, Shao‐Chun, Lianglin Zhang, Gabriel N. Hortobagyi, & Mien‐Chie Hung. (2001). Targeting HER2: Recent developments and future directions for breast cancer patients. Seminars in Oncology. 28(6 Suppl 18). 21–29. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact